DOCS logo

Doximity, Inc. Stock Price

NYSE:DOCS Community·US$9.7b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 73 Fair Values set on narratives written by author

DOCS Share Price Performance

US$51.07
-2.34 (-4.38%)
US$71.11
Fair Value
US$51.07
-2.34 (-4.38%)
28.2% undervalued intrinsic discount
US$71.11
Fair Value
Price US$51.07
AnalystConsensusTarget US$71.11
AnalystHighTarget US$80.00
AnalystLowTarget US$50.42

DOCS Community Narratives

AnalystConsensusTarget·
Fair Value US$71.11 28.2% undervalued intrinsic discount

DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks

0users have liked this narrative
1users have commented on this narrative
32users have followed this narrative
AnalystHighTarget·
Fair Value US$78.58 35.0% undervalued intrinsic discount

Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value US$50 2.1% overvalued intrinsic discount

Privacy Rules Will Squeeze Margins While Tools Will Support Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$50
2.1% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
9.85% p.a.
Profit Margin
35.25%
Future PE
45.1x
Price in 2028
US$61.81

Trending Discussion

Updated Narratives

DOCS logo

DOCS: Pharma Advertising Shift And AI Expansion Will Drive Measured Opportunity And Risks

Fair Value: US$71.11 28.2% undervalued intrinsic discount
32 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
DOCS logo

Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration

Fair Value: US$78.58 35.0% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DOCS logo

Privacy Rules Will Squeeze Margins While Tools Will Support Recovery

Fair Value: US$50 2.1% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record with flawless balance sheet.

0 Risks
4 Rewards

Doximity, Inc. Key Details

US$621.3m

Revenue

US$60.9m

Cost of Revenue

US$560.5m

Gross Profit

US$307.4m

Other Expenses

US$253.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.34
90.20%
40.72%
0%
View Full Analysis

About DOCS

Founded
2010
Employees
830
CEO
Jeffrey Tangney
WebsiteView website
www.doximity.com

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Recent DOCS News & Updates

Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Nov 14
Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Recent updates

No updates